At Creo Medical we are dedicated to improving patient outcomes by bringing advanced energy to therapeutic endoscopy. Our integrated electrosurgery unit delivers Bipolar Radiofrequency for precise dissection and resection and Microwave energy for controlled ablation and coagulation. This technology sets a new standard for Endoscopic Submucosal Dissection with our new Speedboat RS2 instrument: the Bipolar Radiofrequency cut allows precise dissection and the microwave coagulation provides controlled haemostasis while the protective hull reduces the risk of muscle damage and the integrated injection needle helps to maintain submucosal lift without instrument changes.
View Top Employees from Creo MedicalWebsite | http://www.creomedical.com |
Ticker | LSE:CREO |
Revenue | $30.8 million |
Funding | $13.9 million |
Employees | 206 (200 on RocketReach) |
Founded | 2003 |
Phone | +44 1291 606005 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Manufacturing, Medical Equipment Manufacturing, Medical Devices & Equipment, Medical, Health Care, Medical Device |
Web Rank | 24 Million |
Keywords | Creo Medical, Creo Medical Group |
Competitors | Cutera Inc, ENTrigue Surgical, Kebomed Sverige AB, Optimum Medical, Pennine Healthcare |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Creo Medical employee's phone or email?
The Creo Medical annual revenue was $30.8 million in 2024.
200 people are employed at Creo Medical.
The NAICS codes for Creo Medical are [339, 33].
The SIC codes for Creo Medical are [384, 38].